Sona Nanotech’s Breakthrough in Cancer Treatment Study

Sona Nanotech, Inc (TSE:SONA) has released an update.

Sona Nanotech Inc. reports remarkable interim results from its Dalhousie University study, showing an 80% reduction in tumor size from a single Targeted Hyperthermia Therapy treatment using its gold nanorods. Additionally, the company’s latest batch of polymer-coated gold nanorods has shown improved physical uniformity and purity, potentially leading to cost reductions in scaled manufacturing. These advancements may support future regulatory applications and enhance the company’s position in the nanomedicine field.

For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.